administered

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

Call of Duty 2022 Title Has Apparently Been Leaked

Source Node: https://www.dbltap.com/posts/call-of-duty-2022-title-has-apparently-been-leaked-01fhjvjth2ap?utm_source=RSS
Time Stamp: October 9, 2021 1:31 PM - Modified On: October 9, 2021 - Published By:
Source Cluster:
Republished By Plato

Call of DutyPhoto courtesy of ActivisionThe Call of Duty franchise is notoriously bad at containing leaks. Call of Duty 2022 will apparently be called Call of Duty: Modern Warfare II.Tom Henderson, a writer at IGN, confirmed the title of next year's installment on Saturday, Oct. 9. Henderson also added that the game's artwork is reportedly very well done. His confirmation corroborates a leak last month suggesting that CoD 2022 will be a sequel to 2019's Modern Warfare. No other information came from the previous leak, as much is likely still